Molecules at Play in Neurological Diseases 2024
A special issue of Current Issues in Molecular Biology (ISSN 1467-3045). This special issue belongs to the section "Molecular Medicine".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 52
Special Issue Editor
Interests: cancer therapy; cancer biomarker; neurogenomics; systems biology; intercellular communication; neurotransmission
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues，
This Special Issue, “Molecules at Play in Neurological Diseases 2024”, presents a meticulous examination of the molecular mechanisms underpinning diverse neurological disorders. This compilation of articles showcases pioneering research elucidating the roles of specific molecules in the etiology and progression of these conditions.
Contributions to this Special Issue span a spectrum of topics, encompassing the influence of neurotransmitters, neuropeptides, and neurotrophic factors on cerebral function and dysfunction. Researchers delve into the intricate interplay of genetic and epigenetic elements in neurological disorders, illuminating potential therapeutic targets.
Furthermore, this Special Issue underscores the latest advancements in neuroimaging modalities and their utility in diagnosing and monitoring neurological diseases. Insights into the evolution of innovative therapeutic approaches, such as gene therapy and pharmacological interventions, are also detailed.
In summary, "Molecules at Play in Neurological Diseases 2024" offers a comprehensive portrayal of the molecular landscape of neurological disorders. This body of work provides invaluable insights that may pave the way for the development of more efficacious treatments in the future.
Dr. Dumitru Iacobas
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Issues in Molecular Biology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neurological diseases
- neurotransmitters
- neuropeptides
- neurotrophic factors
- genetic and epigenetic elements
